Matrixyl Peptide

$52.00

For Research Use Only. Not for human use. High-purity Matrixyl 3000 (Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7), a patented dual-matrikine complex, supports advanced pre-clinical investigations into extracellular matrix synthesis, fibroblast activation, and dermal remodeling pathways. Investigators utilize this blend to examine upregulation of collagen types I, III, IV, fibronectin, and laminin-5, alongside suppression of MMP-1 and inflammatory mediators in human fibroblast and ex vivo skin models. National Science Labs provides Matrixyl 3000 exclusively for laboratory research exploring matrikine signaling and skin matrix homeostasis in controlled experimental settings.

Out of stock

For Research Use Only — Not for Human Consumption
 

Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Researchers apply Matrixyl 3000 to investigate its mimicry of collagen breakdown fragments, observing stimulation of fibroblast activity and increased synthesis of structural proteins. Pre-clinical findings in human dermal fibroblast cultures indicate dose-dependent elevation of collagen I/III production and extracellular matrix components, with concurrent reduction in matrix metalloproteinase expression.

This dual-peptide complex facilitates examination of matrikine-mediated signaling, fibroblast proliferation, and matrix reorganization in models of photoaging, wound repair, and skin barrier function.

Scientific Overview of Matrixyl 3000 Applications

Pre-clinical models demonstrate Matrixyl 3000’s engagement with dermal matrix mechanisms:

  • Upregulation of collagen I synthesis (up to 350%) and fibronectin (up to 200%) in human fibroblast cultures through matrikine receptor signaling.
  • Stimulation of laminin-5 and hyaluronic acid production, supporting basement membrane integrity and skin hydration in ex vivo tissue models.
  • Suppression of MMP-1 expression and UV-induced matrix degradation in photoaged skin equivalents.
  • Modulation of inflammatory mediators (IL-6, IL-8) and promotion of anti-inflammatory responses in stressed fibroblast systems.
  • Support for investigations into dermal remodeling and re-epithelialization in post-procedure recovery models.
  • Examination of synergistic effects with other matrix-supporting agents in multi-component formulation studies.

For further details on matrikine signaling, collagen synthesis, and dermal matrix pathways in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.

Why Investigators Select National Science Labs Matrixyl 3000

National Science Labs manufactures Matrixyl 3000 under stringent GMP-compliant protocols to ensure batch-to-batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:

  • Purity ≥99% (total peptide content) by HPLC
  • Structural identity confirmation via mass spectrometry (Pal-GHK + Pal-GQPR ratio)
  • Complete Certificate of Analysis (CoA) documentation provided per batch

For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this peptide have not been evaluated by the FDA.

Initiate Your Matrixyl 3000 Research Protocol

Source high-purity Matrixyl 3000 from current limited batches to ensure optimal stability and performance in dermal matrix and collagen synthesis studies.

Additional information

Weight.125 lbs
Dimensions9 × 7 × .5 in

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.